Premenstrual Syndromes : PMS and PMDD - Rutuja :: The site ...

8 THE PREMENSTRUAL SYNDROMES
4. Simon B. Mind and Madness in Ancient Greece: the Classical Roots
of Modern Psychiatry. Ithaca: Cornell University Press; 1978.
5. Halbreich U. History and trajectory of PMS: towards a balanced
adaptation and a biosocial homeostasis. J Reprod Infant Psychol
2006; 24(4):336–46.
6. Prichard J. Treatise on Insanity and Other Disorders Affecting the
Mind. London: Sherwood, Gilbert and Piper; 1837.
7. Brockington I. Menstrual psychosis. World Psychiatry 2005; 4(1):
9–17.
8. Krafft-Ebing R. Psychosis Menstrualis. Stuttgart: Verlag von
Ferdinand Enke; 1902.
9. Horney K. Die Pramenstruellen Verstimmungen. Zeitscher f psychoanalytische
Padagogik 1931; 5:1–7.
10. O’Brien P. Premenstrual Syndrome. London: Blackwell Science;
1987.
11. Moos RH. The development of a menstrual distress questionnaire.
Psychosom Med 1968; 30(6):853–67.
12. American Psychiatric Association. Diagnostic and Statistical
Manual of Mental Health, 4th edn. Washington, DC: American
Psychiatric Press; 1994.
13. Endicott J, Harrison W. Daily rating of severity of problems form.
New York: Department of Research Assessment and Training,
New York State Psychiatric Institute; 1990.
14. Endicott J, Nee J, Harrison W. Daily Record of Severity of Problems
(DRSP): reliability and validity. Arch Womens Ment Health 2006;
9(1):41–9.
15. Wyatt KM, Dimmock PW, Frischer M, Jones PW, O’Brien SPM.
Prescribing patterns in premenstrual syndrome. BMC Womens
Health 2002; 2(1):4.
16. O’Brien PM, Abukhalil IE. Randomized controlled trial of the management
of premenstrual syndrome and premenstrual mastalgia
using luteal phase-only danazol. Am J Obstet Gynecol 1999;
180(1 Pt 1):18–23.
17. Sarno AP Jr, Miller EJ Jr, Lundblad EG. Premenstrual syndrome:
beneficial effects of periodic, low-dose danazol. Obstet Gynecol
1987; 70(1):33–6.
18. Steiner M, Steinberg S, Stewart D et al. Fluoxetine in the treatment
of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual
Dysphoria Collaborative Study Group. N Engl J Med 1995;
332(23):1529–34.
19. Mulrow CD. Rationale for systematic reviews. BMJ 1994; 309
(6954):597–9.
20. Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A
comparison of results of meta-analyses of randomized control
trials and recommendations of clinical experts. Treatments for
myocardial infarction. JAMA 1992; 268(2):240–8.
21. Oxman AD, Guyatt GH. The science of reviewing research. Ann
NY Acad Sci 1993; 703:125–33.
22. Cohen J. Statistical Power Analysis for the Behavioral Sciences.
New Jersey: Lawrence Erlbaum Associates; 1988.
23. Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC.
Meta-analyses of randomized controlled trials. N Engl J Med
1987; 316(8):450–5.
24. Thacker SB. Meta-analysis. A quantitative approach to research
integration. JAMA 1988; 259(11):1685–9.
25. Wyatt K, Dimmock P, Jones P, Obhrai M, O’Brien S. Efficacy of
progesterone and progestogens in management of premenstrual
syndrome: systematic review. BMJ 2001; 323(7316):776–80.
26. Wyatt KM, Dimmock PW, Jones PW, Shaughn O’Brien PM.
Efficacy of vitamin B-6 in the treatment of premenstrual syndrome:
systematic review. BMJ 1999; 318(7195):1375–81.
27. Wyatt KM, Dimmock PW, O’Brien PM. Selective serotonin reuptake
inhibitors for premenstrual syndrome. Cochrane Database
Syst Rev 2002; (4):CD001396.
28. Wyatt KM, Dimmock PW, Ismail KM, Jones PW, O’Brien PM.
The effectiveness of GnRHa with and without ‘add-back’ therapy
in treating premenstrual syndrome: a meta analysis. BJOG 2004;
111(6):585–93.
29. Dimmock PW, Wyatt KM, Jones PW, O’Brien PM. Efficacy of
selective serotonin-reuptake inhibitors in premenstrual syndrome:
a systematic review. Lancet 2000; 356(9236):1131–6.